The ccRCC TME is heterogeneous and unique [16,17], possessing a dense immune cell infiltrate comprising distinct CD8+ and CD4+ T-cell populations (tumour infiltrating lymphocytes (TILs)), with variable expression of activation and costimulatory markers compared to other RCC subtypes. This evidence concerns the gene CD8A and renal cell carcinoma.